News Release
- February 3, 2010
- Third Quarter Consolidated Financial Results for the Fiscal Year Ending March 31, 2010
- January 18, 2010
- MARKETING APPROVAL FOR "MUCODYNE® DS50%"
- January 7, 2010
- Application filed for Orally Disintegrating Tablet of imidafenacin (INN), a Drug for Overactive Bladder
- November 5, 2009
- Execution of License Agreement on Neramexane for Tinnitus with Merz Pharmaceuticals for Japan Territory
- September 29, 2009
- KYORIN and Eisai Sign License Agreement for Development and Marketing of Uritos® Tablets in China, India, Sri Lanka and ASEAN Countries
- August 5, 2009
- First Quarter Consolidated Financial Results for the Fiscal Year Ending March 31, 2010
- July 27, 2009
- Grant of Marketing Right to Senju Pharmaceutical on Gatifloxacin Ophthalmic Solution in China
- April 3, 2009
- Change of Representative Director and President at KYORIN Pharmaceutical
Page Top
